Policy Issues: Filing of Supplemental New Drug Submissions, Supplemental Abbreviated New Drug Submissions, Notifiable Changes and Cross-referenced Submissions
Policy Issues: Filing of Supplemental New Drug Submissions, Supplemental Abbreviated New Drug Submissions, Notifiable Changes and Cross-referenced Submissions is an open dataset from Health Canada with 2 files (HTML); catalogue record updated 2023-09-03. On CanQuery you can follow the original downloads. Files are available in English and French.
The attached policy has been developed to provide for the filing of Supplemental New Drug Submissions, Supplemental Abbreviated New Drug Submissions, Notifiable Changes and Cross-Referenced Submissions in some circumstances prior to the issuance of the Notice of Compliance for the original submission.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2023-09-03
Data overview
- Formats
- HTML
- File languages
- English, French
Official sources and licences
Resources
- Policy Issues: Filing of Supplemental New Drug Submissions, Supplemental Abbreviated New Drug Submissions, Notifiable Changes and Cross-referenced Submissions (French, HTML) HTML · Download HTML
- Policy Issues: Filing of Supplemental New Drug Submissions, Supplemental Abbreviated New Drug Submissions, Notifiable Changes and Cross-referenced Submissions (English, HTML) HTML · Download HTML